Zoekresultaten - Amélie Fontaine

  • Toon 1 - 4 resultaten van 4
Verfijn jouw resultaten
  1. 1
    Skeletal muscle density is an independent predictor of diffuse large B‐cell lymphoma outcomes treated with rituximab‐based chemoimmunotherapy

    Skeletal muscle density is an independent predictor of diffuse large B‐cell lymphoma outcomes treated with rituximab‐based chemoimmunotherapy door Michael P. Chu, Jessica Lieffers, Sunita Ghosh, Andrew R. Belch, Neil Chua, Amélie Fontaine, Randeep Sangha, Robert A. Turner, Vickie E. Baracos, Michael B. Sawyer

    Gepubliceerd in 2016
    Volledige tekst Volledige tekst
    Artigo
    Toevoegen aan favorieten
    Bewaard in:
  2. 2
    Expanded antigen-experienced CD160<sup>+</sup>CD8<sup>+</sup>effector T cells exhibit impaired effector functions in chronic lymphocytic leukemia

    Expanded antigen-experienced CD160<sup>+</sup>CD8<sup>+</sup>effector T cells exhibit impaired effector functions in chronic lymphocytic leukemia door Najmeh Bozorgmehr, Isobel Okoye, Olaide Oyegbami, Lai Xu, Amélie Fontaine, Nanette Cox-Kennett, Loree Larratt, Mark Hnatiuk, Andrei Fagarasanu, Joseph Brandwein, Anthea Peters, Shokrollah Elahi

    Gepubliceerd in 2021
    Volledige tekst Volledige tekst
    Artigo
    Toevoegen aan favorieten
    Bewaard in:
  3. 3
    Skeletal Muscle Radio-Density Is an Independent Predictor of Response and Outcomes in Follicular Lymphoma Treated with Chemoimmunotherapy

    Skeletal Muscle Radio-Density Is an Independent Predictor of Response and Outcomes in Follicular Lymphoma Treated with Chemoimmunotherapy door Michael P. Chu, Jessica Lieffers, Sunita Ghosh, Andrew R. Belch, Neil Chua, Amélie Fontaine, Randeep Sangha, A. Robert Turner, Vickie E. Baracos, Michael B. Sawyer

    Gepubliceerd in 2015
    Volledige tekst Volledige tekst
    Artigo
    Toevoegen aan favorieten
    Bewaard in:
  4. 4
    Proton Pump Inhibitor (Ppis) Therapy May Impair Capecitabine (Cape) Efficacy in Metastatic Gastroesophageal Cancer (Gec), Results from the Trio-013/Logic Trial

    Proton Pump Inhibitor (Ppis) Therapy May Impair Capecitabine (Cape) Efficacy in Metastatic Gastroesophageal Cancer (Gec), Results from the Trio-013/Logic Trial door mingming chu, J. Randolph Hecht, Dennis J. Slamon, Amélie Fontaine, Kathryn King, Sheryl Koski, Karen Mulder, Julie Price Hiller, Andrew Scarfe, Jennifer L. Spratlin, Y-J. Bang, Paulo M. Hoff, A. Sobrero, Shanlin Qin, Karen Afenjar, Vincent Houé, Yudai Huang, S. Khan‐Wasti, Neil Chua, Michael Sawyer

    Gepubliceerd in 2014
    Volledige tekst
    Artigo
    Toevoegen aan favorieten
    Bewaard in:

Zoekinstrumenten: